WallStreetZenWallStreetZen

NASDAQ: CLBT
Cellebrite DI Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLBT

Based on 4 analysts offering 12 month price targets for Cellebrite DI Ltd

Min Forecast
$12.50+0.4%
Avg Forecast
$14.63+17.47%
Max Forecast
$16.00+28.51%

Should I buy or sell CLBT stock?

Based on 4 analysts offering ratings for Cellebrite DI Ltd.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CLBT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CLBT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their CLBT stock forecasts and price targets.

CLBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-15
lockedlocked$00.00+00.00%2026-08-14
lockedlocked$00.00+00.00%2026-08-14
lockedlocked$00.00+00.00%2026-08-14

1 of 1

Forecast return on equity

Is CLBT forecast to generate an efficient return?

Company
42.71%
Industry
50.06%
Market
165.72%
CLBT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLBT forecast to generate an efficient return on assets?

Company
23.12%
Industry
30.6%
CLBT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLBT earnings per share forecast

What is CLBT's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$0.58+151.57%
Avg 2 year Forecast
$0.67+189.13%
Avg 3 year Forecast
$0.82+255.52%
CLBT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CLBT revenue forecast

What is CLBT's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$567.9M+10.42%
Avg 2 year Forecast
$653.8M+27.12%
Avg 3 year Forecast
$758.1M+47.41%
CLBT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLBT earnings growth forecast

How is CLBT forecast to perform vs Software - Infrastructure companies and vs the US market?

Company
51.63%
Industry
26.09%
Market
32.04%
CLBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CLBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CLBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CLBT revenue growth forecast

How is CLBT forecast to perform vs Software - Infrastructure companies and vs the US market?

Company
13.56%
Industry
13.77%
Market
12.32%
CLBT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLBT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLBT vs Software Infrastructure Stocks

TickerPricePrice TargetUp/downsideConsensus
CLBT$12.45$14.63+17.47%Strong Buy
BLSH$21.31$38.43+80.33%Buy
TDC$31.80$35.60+11.95%Hold
SPSC$81.91$80.50-1.72%Hold
WIX$76.09$81.77+7.46%Buy
View Top Software Infrastructure Stocks

Cellebrite DI Stock Forecast FAQ

Is Cellebrite DI Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CLBT) stock is to Strong Buy CLBT stock.

Out of 4 analysts, 3 (75%) are recommending CLBT as a Strong Buy, 1 (25%) are recommending CLBT as a Buy, 0 (0%) are recommending CLBT as a Hold, 0 (0%) are recommending CLBT as a Sell, and 0 (0%) are recommending CLBT as a Strong Sell.

If you're new to stock investing, here's how to buy Cellebrite DI stock.

What is CLBT's earnings growth forecast for 2026-2028?

(NASDAQ: CLBT) Cellebrite DI's forecast annual earnings growth rate of 51.63% is forecast to beat the US Software - Infrastructure industry's average forecast earnings growth rate of 26.09%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.04%.

Cellebrite DI's earnings in 2026 is $58,759,000.On average, 11 Wall Street analysts forecast CLBT's earnings for 2026 to be $143,271,538, with the lowest CLBT earnings forecast at $131,039,229, and the highest CLBT earnings forecast at $153,399,098. On average, 11 Wall Street analysts forecast CLBT's earnings for 2027 to be $164,665,698, with the lowest CLBT earnings forecast at $131,039,229, and the highest CLBT earnings forecast at $189,798,884.

In 2028, CLBT is forecast to generate $202,476,904 in earnings, with the lowest earnings forecast at $174,718,972 and the highest earnings forecast at $219,711,088.

What is CLBT's revenue growth forecast for 2026-2028?

(NASDAQ: CLBT) Cellebrite DI's forecast annual revenue growth rate of 13.56% is not forecast to beat the US Software - Infrastructure industry's average forecast revenue growth rate of 13.77%, and while it is forecast to beat the US market's average forecast revenue growth rate of 12.32%.

Cellebrite DI's revenue in 2026 is $514,289,000.On average, 11 Wall Street analysts forecast CLBT's revenue for 2026 to be $140,614,601,401, with the lowest CLBT revenue forecast at $134,679,207,745, and the highest CLBT revenue forecast at $145,599,143,508. On average, 11 Wall Street analysts forecast CLBT's revenue for 2027 to be $161,884,952,468, with the lowest CLBT revenue forecast at $151,970,344,124, and the highest CLBT revenue forecast at $168,999,005,858.

In 2028, CLBT is forecast to generate $187,726,324,265 in revenue, with the lowest revenue forecast at $177,606,193,321 and the highest revenue forecast at $196,794,080,447.

What is CLBT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CLBT) forecast ROA is 23.12%, which is lower than the forecast US Software - Infrastructure industry average of 30.6%.

What is CLBT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CLBT price target, the average CLBT price target is $14.63, with the highest CLBT stock price forecast at $16.00 and the lowest CLBT stock price forecast at $12.50.

On average, Wall Street analysts predict that Cellebrite DI's share price could reach $14.63 by Sep 15, 2027. The average Cellebrite DI stock price prediction forecasts a potential upside of 17.47% from the current CLBT share price of $12.45.

What is CLBT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CLBT) Cellebrite DI's current Earnings Per Share (EPS) is $0.23. On average, analysts forecast that CLBT's EPS will be $0.58 for 2026, with the lowest EPS forecast at $0.53, and the highest EPS forecast at $0.62. On average, analysts forecast that CLBT's EPS will be $0.67 for 2027, with the lowest EPS forecast at $0.53, and the highest EPS forecast at $0.77. In 2028, CLBT's EPS is forecast to hit $0.82 (min: $0.71, max: $0.89).

What is CLBT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CLBT) forecast ROE is 42.71%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.